{"id":"W4379649420","doi":"10.1136/annrheumdis-2023-eular.1691","title":"POS1536 ASSESSMENT OF PAIN OUTCOMES IN A PHASE 2 TRIAL OF DEUCRAVACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"Samsung; Genentech; Servier; National Institute for Health and Care Research; Celltrion; Kiniksa Pharmaceuticals; Dutch Arthritis Association; Sun Pharma; Regeneron Pharmaceuticals; EMD Serono; University of Pennsylvania; Gilead Sciences; Sanofi; GlaxoSmithKline; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Physical therapy; Arthritis; Antirheumatic Agents; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003371201,0.0001274086,0.0006718118,0.0002025305,0.00001423458,0.000002917878,0.0001155389,0.00003070266,0.00003293059],"category_scores_gemma":[0.001040827,0.00007913626,0.0001676409,0.0004698867,0.0001029083,0.00006972082,0.0000449649,0.00006156999,7.617243e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001204447,"about_ca_system_score_gemma":0.0001593577,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001876586,"about_ca_topic_score_gemma":0.00003958394,"domain_scores_codex":[0.9984013,0.0001743932,0.000640007,0.000126611,0.0004768593,0.0001808194],"domain_scores_gemma":[0.9987126,0.0004473882,0.000388528,0.0002793794,0.0001060867,0.000066028],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03437886,0.01281518,0.6791235,0.001174959,0.000538749,0.000009813939,0.001370644,0.0002212881,0.000007247409,0.0003245846,0.0005417266,0.2694935],"study_design_scores_gemma":[0.05984606,0.00216646,0.9335099,0.001653446,0.00006626711,1.177553e-7,0.001062013,0.0004734648,0.00005115811,0.001090574,0.000001722162,0.00007882609],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979963,0.0001008835,0.00001641697,0.0005413814,0.00003968478,0.001043962,0.0001658515,0.000009059684,0.00008645286],"genre_scores_gemma":[0.9996048,0.0001556206,0.0000406261,0.00007478874,0.00000374268,0.00004921653,0.00004335941,0.0000124974,0.00001533747],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2694146,"threshold_uncertainty_score":0.3227083,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02611277474082342,"score_gpt":0.3490589343388839,"score_spread":0.3229461595980605,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}